510(k) Report

510(k) · Cleared

Cleared

Askina Hydrocolloid/Thin

K973227510(k) TraditionalCleared Jan 28, 1999519-day reviewClass I21 CFR 880.5090

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

B.Braun Medical, Inc. · KMF Bandage, Liquid

Cleared on Jan 28, 1999 as substantially equivalent to K881050 (Convatec, A Division of E.R. Squibb & Sons, 1988) after a 519-day review. Its family tree reaches back 1 generation to 1988.

Decided
Jan 28, 1999
Review
519 days
Class
Class I
Product code
KMF
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K881050 (1988). No later device cites it as a predicate yet.

K881050 · Duoderm (R) CGF · Convatec, A Division of E.R. Squibb & Sons · 19881985199019952000
  1. Root · 1 generation backK881050 Duoderm (R) CGFConvatec, A Division of E.R. Squibb & Sons · 1988
  2. This deviceK973227 Askina Hydrocolloid/ThinB.Braun Medical, Inc. · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K881050Duoderm (R) CGFConvatec, A Division of E.R. Squibb & Sons1988—
0 (this device)K973227Askina Hydrocolloid/ThinB.Braun Medical, Inc.1999—
FIG. 1 — Lineage of K973227, 1988–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KMF device

  1. #1 K241916 TearRepair Liquid Skin Protectantscore 8.1 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K881050Duoderm (R) CGF
Summary page 1
…colloid Trade Name: Dressing Classification name: General and Plastic Surgery Class |, 80FRO 21 CFR 878.4060 SUBSTANTIAL EQUIVALENCE! TO: o Jg*'fwmm«s T | ; | | | K881050 Squibb & Sons, Inc. Device Description: In accordance with section 510(k) for the Federal Food, Drug, and Cosmetic Act, B. Bra…
Convatec, A Division of E.R. Squibb & Sons1988—

Also cleared against K881050: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K881050.

How does its category compare?

All KMF devices

KMF Bandage, Liquid: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KMF

1in 2024

2007: 22008: 32009: 32010: 12012: 12014: 22016: 22018: 12019: 12024: 1
2007high 3 (2008) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KMF

213in 2009

2008: 35 days median2009: 213 days median
2007high 213 (2009) · low 35 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KMF

1in 2011

2007: 12011: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KMF

12in 2025

2007: 62008: 22009: 62010: 72011: 162012: 32013: 342014: 242015: 132016: 182017: 162018: 102019: 62020: 82021: 102022: 72023: 62024: 62025: 12
2007high 34 (2013) · low 2 (2008)2025

MAUDE reports naming product code KMF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—16
200833502
2009321306
20101—07
20110—116
20121—03
20130—034
20142—024
20150—013
20162—018
20170—016
20181—010
20191—06
20200—08
20210—010
20220—07
20230—06
20241—06
20250—012
20260—0—

What is it indicated for?

Askina Hydrocolloid and Askina Hydrocolloid/Thin react with a wound exudate to form a soft gel which permits dressing removal with minimal damage to newly formed tissue. It may be used for superficial wounds e.g. minor abrasions. It may also be used for the following indications under the supervision of a healthcare professional:

Dermal Ulcers, including

Partial & Full Thickness Wounds

Pressure Ulcers, Stages I-IV

Arterial and Venous Leg Ulcers

Burns — Second Degree

Donor Sites

As an Aid in the Prevention of Skin Breakdown

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973227: Askina Hydrocolloid/Thin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K973227

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026